lacking

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

Source Node:
Time Stamp: December 29, 2023 3:07 AM - Modified On: December 29, 2023 - Published By:
Source Cluster:
Republished By Plato

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced

JBL Quantum TWS Air Review: Sometimes less is more

Source Node:
Time Stamp: August 8, 2023 12:35 PM - Modified On: August 8, 2023 - Published By:
Source Cluster:
Republished By Plato

The JBL Quantum TWS Air headphones have improved sound quality over the previous model and are perfect for low-latency gaming with the included USB-C dongle. The redesigned headphones have a lightweight and comfortable fit, but some users may experience issues operating the overly sensitive touch buttons. The headphones offer solid connectivity with Bluetooth 5.3 and an included USB-C dongle, and have a good battery life of up to 24 hours. In 2022, JBL launched the Quantum TWS headphones. They were pretty average except for a USB-C dongle which made them